US-based DermaSensor has announced a newly published study showing that its AI-powered device can improve a primary care physician’s ability to assess moles of concern. In the prospective study, ...

The advanced development of medical technology has accelerated in recent years, with devices being continuously manufactured for healthcare professionals as well as consumers at home. From wellbeing ...

MIAMI--(BUSINESS WIRE)--DermaSensor Inc., a health technology company designing non-invasive tools to better equip primary care physicians for skin cancer detection, today announced the publication of ...

The Food and Drug Administration has authorized the first artificial intelligence-powered medical device to help doctors detect the most common forms of skin cancer in patients. The technology, from ...

Please provide your email address to receive an email when new articles are posted on . The device is a handheld tool that uses spectroscopy and algorithms to test worrisome skin lesions for cancer.

MIAMI--(BUSINESS WIRE)--DermaSensor Inc., a health technology company equipping primary care physicians (PCPs) with a non-invasive device for use in evaluation of suspicious skin lesions, presented to ...

BOSTON - One in five Americans will develop skin cancer in their lifetime but it can be hard to tell the difference between a benign mole and cancer during a routine. Now, a new AI-powered device ...

The DermaSensor device is an affordable, handheld device that uses machine learning and spectroscopy to automatically test skin lesions for potential cancer. DermaSensor's optical spectroscopy and ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Florida native leads a ...

EINPresswire/ -- DermaSensor Inc., a medical device technology company transforming skin cancer detection for frontline care, today announced it has raised $16 million in Series B funding to fuel the ...